Raymond James Financial Weighs in on TSE:GUD FY2025 Earnings
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Analysts at Raymond James Financial raised their FY2025 EPS estimates for Knight Therapeutics in a research report issued on Wednesday, June 18th. Raymond James Financial analyst M. Freeman now expects that the company will post earnings of $0.15 per share for the year, up from their previous […]
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Analysts at Raymond James Financial raised their FY2025 EPS estimates for Knight Therapeutics in a research report issued on Wednesday, June 18th. Raymond James Financial analyst M. Freeman now expects that the company will post earnings of $0.15 per share for the year, up from their previous […]
